Drug Trial Radar · NCT05616013
Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese
Last checked: Nov 19, 2026Latest source record: Jul 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
507
Actual
Start
Nov 16, 2022
Primary completion
May 16, 2024
Study completion Jun 14, 2025
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- Collaborators
- Versanis Bio, Inc.
- First posted
- Nov 14, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A phase 2 study to assess the efficacy of bimagrumab alone or in addition to semaglutide to assess efficacy and safety in overweight or obese men and women
Conditions
- Obesity
- Obese
- Overweight or Obesity
Interventions
BimagrumabBiological
Human monoclonal antibody to the activin receptor type II
SemaglutideDrug
Glucagon-like peptide-1 (GLP-1) receptor agonist
PlaceboOther
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Body Weight at Week 48Time frame: Baseline, Week 48
Locations
26 sites in 3 countries. Site status is shown where the registry gives one.
Pinnacle Research Group, LLC
Anniston, Alabama
Cullman Clinical Trials
Cullman, Alabama
Indago Research & Health Center, Inc
Hialeah, Florida
Clinical Neuroscience Solutions Inc
Jacksonville, Florida
Altus Research
Lake Worth, Florida
Pennington Biomedical Research Center
Baton Rouge, Louisiana
Weill Cornell Medical College
New York, New York
Monroe Biomedical Research
Monroe, North Carolina
SPICA Clinical
Columbia, South Carolina
Mt. Olympus Medical Research
Sugar Land, Texas
Emeritus Research
Camberwell, Australia
Northern Beaches Clinical Research
Brookvale, New South Wales, Australia
Royal North Shore Hospital
Saint Leonards, New South Wales, Australia
University of The Sunshine Coast Morayfield
Morayfield, Queensland, Australia
University of the Sunshine Coast Clinical Trial Centre
Sippy Downs, Queensland, Australia
University of The Sunshine Coast South Brisbane
South Brisbane, Queensland, Australia
Gold Coast University Hospital
Southport, Queensland, Australia
Austin Health
Heidelberg Heights, Victoria, Australia
New Zealand Clinical Research Auckland
Auckland, New Zealand
Optimal Clinical Trials
Auckland, New Zealand
Middlemore Hospital
Auckland, New Zealand
New Zealand Clinical Research Christchurch
Christchurch, New Zealand
Lakeland Clinical Trials Waikato
Hamilton, New Zealand
Southern Clinical Trials Tasman
Nelson, New Zealand
Southern Clinical Trials Ltd
Beckenham, Christchurch, Canterbury, New Zealand
P3 Research
Newtown, Wellington Region, New Zealand
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.